Population
Cardiac ischemic preconditioning models (specific model not stated)
Design
Preclinical
Authors
Loading...
Positions MG53 as potential target in ischemic heart disease; leaves open whether targeting it improves patient outcomes.
MG53 is identified as a primary determinant of cardiac ischemic preconditioning, highlighting it as a potential therapeutic target for ischemic heart disease.
Cao et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: